An innovative approach could transform the treatment landscape for DLBCL patients, offering hope to those who might otherwise ...

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...

Heart diseases are increasing among young adults. While common cardiovascular conditions, such as high cholesterol or irregular heartbeats, are widely known and can lead to heart attacks, there's one ...

The accelerated approval is for the treatment of adult and pediatric patients aged one year and older with diffuse midline glioma harboring an H3 K27M mutation and progressive disease following prior ...

Diffuse coronary artery disease is a subtype of coronary artery disease (CAD) in which larger sections of coronary arteries have a high plaque buildup. It is less common than focal CAD and can be more ...

Kazia Therapeutics Limited (NASDAQ: KZIA), a clinical-stage biotechnology company developing innovative therapies for brain cancers, today announced its participation in a fully funded Australian ...

Sebastian Guerra was an otherwise typical 10-year-old who faced an extraordinary battle with bravery. He was diagnosed with ...

Cardiologist flagged warning about a hard to treat heart disease where the plaque builds up in multiple branches of arteries.